Home > EMCDDA Trendspotter study on fentanyl in Europe.

European Monitoring Centre for Drugs and Drug Addiction. (2012) EMCDDA Trendspotter study on fentanyl in Europe. Luxembourg: Publications Office of the European Union.

[img] PDF (Fentanyl in Europe) - Published Version
PDF (Innovative methods for exploring new drug-related trends: the EMCDDA Trendspotter methodology (poster)) - Supplemental Material

The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9–10 October 2012. The aim of the study was to increase understanding of the availability and illicit use of fentanyl in Europe, with a specific focus on: the extent and patterns of use; illicit production and diversion; harms and deaths; and, responses to the problem. Twelve experts from 10 EU Member States (Bulgaria, Czech Republic, Germany, Estonia, Greece, Italy, Slovakia, Sweden, Finland, United Kingdom) attended the meeting, presenting their experiences and contributing to an analysis of the topic, providing insights from law enforcement, forensics, treatment, research and monitoring, and drug user perspectives.

Table of contents
• Rationale and methods
• Multiple sources of supply
• Divergent situations regarding use
• Why more fentanyl use?
• High levels of harm
• Responding to fentanyl problems
• Discussion
• Conclusion

Item Type
Publication Type
International, Report
Drug Type
Opioid, New psychoactive substance
Intervention Type
Harm reduction
14 p.
Publications Office of the European Union
Corporate Creators
European Monitoring Centre for Drugs and Drug Addiction
Place of Publication
Accession Number
HRB (Electronic Only)
Related (external) link

Repository Staff Only: item control page